Modified Risk Tobacco Products The modified risk tobacco product (MRTP) pathway is outlined in the 2009 Family Smoking prevention and Tobacco Control Act [and] allows companies to submit applications for the FDA to evaluate whether a tobacco product may be sold or distributed for use to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco products. The FDA maintains that the products authorized to be marketed with this claim are neither safe nor FDA-approved
The IQOS product line includes several models of tobacco heaters, and each device works in a specific way
Casas-Recasens S, Noell G, Mendoza N, Lopez-Giraldo A, Garcia T, Guirao A, et al
Whenever you feel nasal congestion or other stuffy nose symptoms, like sneezing, fever, and postnasal drip, persist for more than ten days, you need to seek medical attention